alfuzosin hydrochloride extended release alfuzosin hydrochloride tablet

1 INDICATIONS AND USAGE Alfuzosin hydrochloride is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Alfuzosin hydrochloride is an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. ( 1 ) Important Limitations of Use: Alfuzosin hydrochloride is not indicated for the treatment of hypertension. ( 1.1 ) Alfuzosin hydrochloride is not indicated for use in the pediatric population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use Alfuzosin hydrochloride is not indicated for the treatment of hypertension. Alfuzosin hydrochloride is not indicated for use in the pediatric population.

camber pharmaceuticals

FDA Reported Adverse Reactions
`[1] nausea` `[2] drug ineffective` `[3] fatigue` `[4] pain` `[5] diarrhoea` `[6] vomiting` `[7] off label use` `[8] headache` `[9] dyspnoea` `[10] pyrexia`

4 years ago

ROUND WHITE IG 302

4 years ago

IG 302 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Alfuzosin hydrochloride is supplied as follows: Alfuzosin hydrochloride extended-release tablets 10 mg are available as off white, round, biconvex tablets debossed with ‘IG’ on one side and “302” on other. Alfuzosin hydrochloride is supplied as follows: Package NDC Number Bottles of 30 31722-302-30 Bottles of 100 31722-302-01 Bottles of 500 31722-302-05 Store at 20° to 25°C (68° to 77°F) [see USP]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP. Keep alfuzosin hydrochloride out of reach of children.

More pills like ROUND IG 302

Related Pills

Alfuzosin hydrochloride 24 HR Alfuzosin hydrochloride 10 MG Extended Release Oral Tablet

Exelan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site